| 1.6 |
12.8 |
GO:0003065 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.5 |
4.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 1.4 |
4.2 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 1.3 |
3.9 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 1.3 |
3.9 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 1.2 |
3.7 |
GO:2000064 |
regulation of cortisol biosynthetic process(GO:2000064) |
| 1.2 |
4.9 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 1.2 |
3.6 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 1.0 |
4.0 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
| 0.9 |
0.9 |
GO:0050932 |
regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
| 0.7 |
2.2 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.7 |
2.8 |
GO:0009296 |
obsolete flagellum assembly(GO:0009296) |
| 0.7 |
1.4 |
GO:0045989 |
positive regulation of striated muscle contraction(GO:0045989) |
| 0.7 |
4.1 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.7 |
4.7 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.7 |
4.7 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) negative regulation of cell volume(GO:0045794) |
| 0.7 |
4.0 |
GO:1903960 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
| 0.6 |
0.6 |
GO:2000178 |
negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.6 |
1.9 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.6 |
1.9 |
GO:0021837 |
motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) regulation of mesodermal cell fate specification(GO:0042661) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) regulation of mesoderm development(GO:2000380) |
| 0.6 |
1.8 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.6 |
1.2 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.6 |
3.6 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.6 |
1.2 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.6 |
2.4 |
GO:0045112 |
integrin biosynthetic process(GO:0045112) |
| 0.6 |
8.7 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.5 |
1.6 |
GO:0043371 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
| 0.5 |
1.6 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.5 |
1.6 |
GO:1903115 |
regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
| 0.5 |
1.0 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.5 |
1.6 |
GO:2000121 |
regulation of removal of superoxide radicals(GO:2000121) |
| 0.5 |
1.5 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.5 |
1.5 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.5 |
3.0 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.5 |
1.5 |
GO:0043418 |
cysteine biosynthetic process from serine(GO:0006535) homoserine metabolic process(GO:0009092) cysteine biosynthetic process via cystathionine(GO:0019343) transsulfuration(GO:0019346) homocysteine catabolic process(GO:0043418) |
| 0.5 |
0.5 |
GO:0010821 |
regulation of mitochondrion organization(GO:0010821) |
| 0.5 |
1.5 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.5 |
1.5 |
GO:1990170 |
detoxification of cadmium ion(GO:0071585) stress response to cadmium ion(GO:1990170) |
| 0.5 |
4.8 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.5 |
3.3 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.5 |
2.4 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.5 |
2.8 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.5 |
1.9 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.5 |
2.3 |
GO:0044854 |
membrane raft assembly(GO:0001765) plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) membrane assembly(GO:0071709) |
| 0.5 |
4.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 |
1.4 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.4 |
1.3 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.4 |
0.4 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.4 |
1.3 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.4 |
4.6 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.4 |
14.3 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.4 |
1.2 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.4 |
1.7 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.4 |
2.5 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.4 |
0.4 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.4 |
0.4 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.4 |
1.2 |
GO:0032196 |
transposition, DNA-mediated(GO:0006313) transposition(GO:0032196) |
| 0.4 |
0.4 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.4 |
2.8 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.4 |
0.4 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.4 |
3.9 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.4 |
0.8 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) renal vesicle formation(GO:0072033) |
| 0.4 |
1.5 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.4 |
1.9 |
GO:0046349 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
| 0.4 |
0.4 |
GO:0009267 |
cellular response to starvation(GO:0009267) |
| 0.4 |
1.5 |
GO:0090594 |
wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
| 0.4 |
0.8 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.4 |
1.1 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.4 |
3.4 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.4 |
1.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.4 |
1.1 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.4 |
0.7 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.4 |
1.1 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.4 |
1.8 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.4 |
2.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.4 |
1.8 |
GO:0019471 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
| 0.4 |
0.7 |
GO:0090047 |
obsolete positive regulation of transcription regulator activity(GO:0090047) |
| 0.4 |
0.4 |
GO:0010915 |
regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.4 |
1.1 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 |
1.0 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.3 |
3.8 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.3 |
1.0 |
GO:0061687 |
detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) stress response to copper ion(GO:1990169) |
| 0.3 |
0.7 |
GO:0045415 |
negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.3 |
2.7 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.3 |
2.4 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 0.3 |
1.0 |
GO:0042727 |
flavin-containing compound metabolic process(GO:0042726) flavin-containing compound biosynthetic process(GO:0042727) |
| 0.3 |
1.7 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.3 |
3.0 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.3 |
2.0 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.3 |
0.6 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.3 |
1.6 |
GO:0010759 |
regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.3 |
1.3 |
GO:0010900 |
regulation of phosphatidylcholine catabolic process(GO:0010899) negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.3 |
0.6 |
GO:0051297 |
microtubule organizing center organization(GO:0031023) centrosome organization(GO:0051297) |
| 0.3 |
0.3 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.3 |
0.3 |
GO:0044774 |
mitotic DNA integrity checkpoint(GO:0044774) |
| 0.3 |
0.3 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.3 |
0.6 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.3 |
3.4 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 |
0.9 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.3 |
0.9 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.3 |
2.8 |
GO:0048261 |
negative regulation of receptor-mediated endocytosis(GO:0048261) |
| 0.3 |
0.3 |
GO:0031943 |
regulation of glucocorticoid metabolic process(GO:0031943) |
| 0.3 |
0.3 |
GO:0001880 |
Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
| 0.3 |
1.2 |
GO:0060839 |
radial pattern formation(GO:0009956) lymphatic endothelial cell fate commitment(GO:0060838) endothelial cell fate commitment(GO:0060839) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.3 |
1.2 |
GO:1903170 |
negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
| 0.3 |
0.6 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.3 |
1.2 |
GO:0010882 |
regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
| 0.3 |
0.9 |
GO:0010837 |
regulation of keratinocyte proliferation(GO:0010837) |
| 0.3 |
0.9 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.3 |
2.7 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.3 |
1.5 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.3 |
0.9 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 |
1.4 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.3 |
0.6 |
GO:2000008 |
regulation of protein localization to cell surface(GO:2000008) |
| 0.3 |
0.9 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.3 |
0.8 |
GO:0071883 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.3 |
0.3 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.3 |
0.6 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.3 |
1.4 |
GO:0003070 |
age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) |
| 0.3 |
1.7 |
GO:1902622 |
regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
| 0.3 |
0.6 |
GO:1904358 |
positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
| 0.3 |
1.4 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.3 |
1.1 |
GO:0042483 |
negative regulation of odontogenesis(GO:0042483) |
| 0.3 |
1.1 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.3 |
0.8 |
GO:0060347 |
heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
| 0.3 |
7.2 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.3 |
1.3 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.3 |
0.3 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
| 0.3 |
2.1 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.3 |
1.3 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.3 |
0.8 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.3 |
0.5 |
GO:0035120 |
post-embryonic appendage morphogenesis(GO:0035120) |
| 0.3 |
0.3 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.3 |
0.8 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.3 |
1.0 |
GO:1902414 |
protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
| 0.3 |
0.5 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.3 |
0.5 |
GO:0071377 |
response to glucagon(GO:0033762) cellular response to glucagon stimulus(GO:0071377) |
| 0.3 |
1.5 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.2 |
6.2 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.2 |
1.0 |
GO:0045445 |
myoblast differentiation(GO:0045445) |
| 0.2 |
1.5 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.2 |
0.7 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.2 |
0.2 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.2 |
1.5 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 |
0.2 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.2 |
4.5 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.2 |
1.0 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.2 |
1.4 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.2 |
4.8 |
GO:0043462 |
regulation of ATPase activity(GO:0043462) |
| 0.2 |
0.5 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.2 |
0.2 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.2 |
1.4 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.2 |
0.9 |
GO:0090267 |
positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.2 |
1.7 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.2 |
0.5 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.2 |
0.7 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.2 |
0.9 |
GO:0071379 |
cellular response to prostaglandin stimulus(GO:0071379) |
| 0.2 |
0.7 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
0.7 |
GO:0014063 |
regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.2 |
1.2 |
GO:0010544 |
negative regulation of platelet activation(GO:0010544) |
| 0.2 |
0.7 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.2 |
0.2 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.2 |
0.5 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.2 |
0.7 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.2 |
0.2 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 |
0.7 |
GO:0021570 |
rhombomere 4 development(GO:0021570) |
| 0.2 |
0.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 |
0.9 |
GO:0010716 |
regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
| 0.2 |
0.7 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.2 |
0.5 |
GO:0014044 |
Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.2 |
0.7 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.2 |
0.2 |
GO:0032909 |
transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.2 |
1.3 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.2 |
1.3 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.2 |
0.4 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.2 |
0.4 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.2 |
0.2 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 |
0.9 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) |
| 0.2 |
2.6 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.2 |
2.0 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.2 |
GO:0002673 |
regulation of acute inflammatory response(GO:0002673) |
| 0.2 |
0.6 |
GO:0071107 |
response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
0.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
0.4 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.2 |
1.3 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.2 |
0.6 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
1.9 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.2 |
0.6 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) |
| 0.2 |
0.6 |
GO:1901142 |
insulin processing(GO:0030070) insulin metabolic process(GO:1901142) |
| 0.2 |
0.8 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
0.2 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.2 |
4.3 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.2 |
3.1 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.2 |
0.4 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.2 |
2.9 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
| 0.2 |
0.8 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.2 |
1.4 |
GO:0003091 |
renal water homeostasis(GO:0003091) |
| 0.2 |
0.2 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
| 0.2 |
1.0 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.2 |
3.4 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.2 |
0.8 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.2 |
0.6 |
GO:2000105 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) positive regulation of DNA-dependent DNA replication(GO:2000105) |
| 0.2 |
1.0 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.2 |
0.2 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.2 |
0.2 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 |
0.4 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.2 |
2.1 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.2 |
0.2 |
GO:0007109 |
obsolete cytokinesis, completion of separation(GO:0007109) |
| 0.2 |
0.2 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.2 |
1.0 |
GO:0035444 |
nickel cation transport(GO:0015675) vanadium ion transport(GO:0015676) ferrous iron transport(GO:0015684) lead ion transport(GO:0015692) nickel cation transmembrane transport(GO:0035444) ferrous iron import(GO:0070627) iron ion import(GO:0097286) |
| 0.2 |
0.2 |
GO:0042519 |
negative regulation of interleukin-17 production(GO:0032700) tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
| 0.2 |
1.3 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.2 |
1.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
1.0 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
0.6 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.2 |
5.3 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.2 |
0.6 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.2 |
0.9 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.2 |
0.4 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.2 |
0.6 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.2 |
0.8 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
0.8 |
GO:0048704 |
embryonic skeletal system morphogenesis(GO:0048704) |
| 0.2 |
13.7 |
GO:0034249 |
negative regulation of translation(GO:0017148) negative regulation of cellular amide metabolic process(GO:0034249) |
| 0.2 |
0.6 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.2 |
1.3 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.2 |
0.7 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.2 |
1.1 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.2 |
5.5 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.2 |
0.6 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.2 |
0.5 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.2 |
0.7 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 |
1.8 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.2 |
0.9 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.2 |
0.7 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.2 |
1.1 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.2 |
0.4 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.2 |
0.7 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.2 |
0.7 |
GO:0033688 |
regulation of osteoblast proliferation(GO:0033688) |
| 0.2 |
3.4 |
GO:0072595 |
maintenance of protein location in nucleus(GO:0051457) maintenance of protein localization in organelle(GO:0072595) |
| 0.2 |
0.2 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
| 0.2 |
0.5 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.2 |
1.4 |
GO:0031274 |
pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 |
1.7 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.2 |
0.5 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.2 |
0.5 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.2 |
0.5 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.2 |
1.0 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.2 |
0.2 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.2 |
1.0 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 |
0.2 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.2 |
1.5 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
1.5 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.2 |
1.0 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.2 |
3.4 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.2 |
0.3 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.2 |
0.7 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
1.0 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.2 |
0.3 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.2 |
2.7 |
GO:0034329 |
cell junction assembly(GO:0034329) |
| 0.2 |
1.0 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
0.3 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
| 0.2 |
0.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 |
0.2 |
GO:0051789 |
obsolete response to protein(GO:0051789) |
| 0.2 |
0.3 |
GO:0051145 |
smooth muscle cell differentiation(GO:0051145) |
| 0.2 |
0.7 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.2 |
0.5 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 |
0.2 |
GO:0048557 |
embryonic digestive tract morphogenesis(GO:0048557) |
| 0.2 |
0.3 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.2 |
0.6 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.2 |
0.6 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.2 |
1.0 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 |
0.3 |
GO:0048488 |
synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
| 0.2 |
0.2 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.2 |
0.2 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.2 |
11.0 |
GO:0030198 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.2 |
0.3 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.2 |
0.2 |
GO:0008589 |
regulation of smoothened signaling pathway(GO:0008589) |
| 0.2 |
1.2 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.2 |
1.2 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.2 |
0.2 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.2 |
0.5 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.2 |
0.9 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.2 |
0.8 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.2 |
1.2 |
GO:0070972 |
protein localization to endoplasmic reticulum(GO:0070972) |
| 0.2 |
2.0 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.2 |
0.3 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 |
0.2 |
GO:0008291 |
acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 0.2 |
0.9 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 |
0.5 |
GO:0046210 |
nitric oxide catabolic process(GO:0046210) |
| 0.2 |
2.1 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.2 |
0.5 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.2 |
0.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
1.1 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.2 |
0.6 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.1 |
0.3 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.1 |
0.4 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.6 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 0.1 |
1.2 |
GO:0043114 |
regulation of vascular permeability(GO:0043114) |
| 0.1 |
0.1 |
GO:0050665 |
hydrogen peroxide biosynthetic process(GO:0050665) |
| 0.1 |
0.4 |
GO:0051231 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.1 |
0.7 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
0.6 |
GO:0090178 |
establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 |
0.4 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
0.4 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
2.2 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 |
0.7 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.1 |
0.6 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.3 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.3 |
GO:0044273 |
sulfur compound catabolic process(GO:0044273) |
| 0.1 |
0.7 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
| 0.1 |
0.4 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.1 |
0.4 |
GO:0019319 |
hexose biosynthetic process(GO:0019319) |
| 0.1 |
0.6 |
GO:0060209 |
estrus(GO:0060209) |
| 0.1 |
3.7 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 |
0.3 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 |
0.6 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.1 |
0.6 |
GO:0015840 |
urea transport(GO:0015840) |
| 0.1 |
0.7 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 |
0.1 |
GO:0016241 |
regulation of macroautophagy(GO:0016241) |
| 0.1 |
0.4 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 |
0.3 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.1 |
1.8 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.4 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.1 |
0.3 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.8 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.6 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.4 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.4 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.1 |
0.4 |
GO:0034616 |
response to laminar fluid shear stress(GO:0034616) |
| 0.1 |
0.1 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 |
0.4 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
| 0.1 |
0.8 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.1 |
0.3 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.3 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.1 |
0.4 |
GO:0060178 |
exocyst assembly(GO:0001927) regulation of exocyst assembly(GO:0001928) exocyst localization(GO:0051601) regulation of exocyst localization(GO:0060178) |
| 0.1 |
1.0 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.5 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.9 |
GO:0070168 |
negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
| 0.1 |
0.5 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
2.4 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 |
0.4 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
1.7 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
| 0.1 |
0.1 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
0.3 |
GO:0002890 |
negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
| 0.1 |
1.5 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.1 |
1.1 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
0.3 |
GO:0072283 |
mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) metanephric renal vesicle morphogenesis(GO:0072283) |
| 0.1 |
0.4 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.1 |
0.7 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.7 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.1 |
0.4 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.1 |
GO:0032898 |
neurotrophin production(GO:0032898) |
| 0.1 |
0.5 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.1 |
0.8 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
1.0 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.1 |
0.1 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.1 |
0.4 |
GO:0002124 |
territorial aggressive behavior(GO:0002124) brainstem development(GO:0003360) vocalization behavior(GO:0071625) |
| 0.1 |
1.3 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
1.3 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
4.5 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
0.1 |
GO:0045606 |
positive regulation of epidermal cell differentiation(GO:0045606) |
| 0.1 |
1.0 |
GO:0032528 |
microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
| 0.1 |
0.4 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.1 |
0.8 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
0.6 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.1 |
0.9 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.4 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
2.0 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.1 |
0.6 |
GO:0007435 |
salivary gland morphogenesis(GO:0007435) |
| 0.1 |
0.5 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
0.4 |
GO:0032908 |
transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
| 0.1 |
0.5 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.2 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) regulation of meiosis I(GO:0060631) |
| 0.1 |
0.4 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.6 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.7 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.2 |
GO:0002220 |
innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
| 0.1 |
0.4 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
0.5 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.8 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
0.5 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.1 |
GO:0016331 |
morphogenesis of embryonic epithelium(GO:0016331) |
| 0.1 |
0.2 |
GO:0060840 |
artery morphogenesis(GO:0048844) artery development(GO:0060840) |
| 0.1 |
0.2 |
GO:0008049 |
male courtship behavior(GO:0008049) |
| 0.1 |
0.2 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.8 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.2 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.1 |
0.1 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 |
0.9 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
0.2 |
GO:0097061 |
dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
| 0.1 |
0.1 |
GO:0043501 |
skeletal muscle adaptation(GO:0043501) |
| 0.1 |
0.6 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
0.2 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
1.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 |
0.3 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 |
3.2 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 |
0.6 |
GO:0032717 |
negative regulation of interleukin-8 production(GO:0032717) |
| 0.1 |
0.3 |
GO:0018377 |
N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.1 |
0.2 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.8 |
GO:0007549 |
dosage compensation(GO:0007549) |
| 0.1 |
0.2 |
GO:0010595 |
positive regulation of endothelial cell migration(GO:0010595) |
| 0.1 |
0.2 |
GO:0032236 |
obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
| 0.1 |
0.8 |
GO:0010799 |
regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 |
1.5 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 |
2.4 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
2.8 |
GO:0016236 |
macroautophagy(GO:0016236) |
| 0.1 |
1.0 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.4 |
GO:0072180 |
nephric duct development(GO:0072176) mesonephric duct development(GO:0072177) nephric duct morphogenesis(GO:0072178) mesonephric duct morphogenesis(GO:0072180) |
| 0.1 |
0.3 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
1.1 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.1 |
0.1 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
0.5 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
1.0 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.1 |
0.2 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.1 |
2.8 |
GO:0006914 |
autophagy(GO:0006914) |
| 0.1 |
1.8 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
0.4 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
0.3 |
GO:0007184 |
SMAD protein import into nucleus(GO:0007184) |
| 0.1 |
0.8 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.3 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 |
0.2 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.1 |
0.2 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.1 |
0.1 |
GO:0030146 |
obsolete diuresis(GO:0030146) |
| 0.1 |
0.8 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.1 |
GO:0022601 |
menstrual cycle phase(GO:0022601) |
| 0.1 |
0.3 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.1 |
0.3 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.1 |
GO:0009791 |
post-embryonic development(GO:0009791) |
| 0.1 |
0.8 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.1 |
0.6 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
1.7 |
GO:0000768 |
syncytium formation by plasma membrane fusion(GO:0000768) syncytium formation(GO:0006949) myoblast fusion(GO:0007520) |
| 0.1 |
0.1 |
GO:0090342 |
regulation of cell aging(GO:0090342) |
| 0.1 |
0.5 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.1 |
0.1 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
1.4 |
GO:0002040 |
sprouting angiogenesis(GO:0002040) |
| 0.1 |
2.7 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.1 |
0.5 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 |
2.8 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
0.6 |
GO:0015780 |
nucleotide-sugar transport(GO:0015780) |
| 0.1 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.8 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.1 |
0.8 |
GO:0045408 |
regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.1 |
0.2 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
0.5 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.1 |
0.6 |
GO:0010226 |
response to lithium ion(GO:0010226) |
| 0.1 |
1.6 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.4 |
GO:0006922 |
obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
| 0.1 |
1.0 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 |
0.2 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.1 |
0.4 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.1 |
0.3 |
GO:0051271 |
negative regulation of cellular component movement(GO:0051271) |
| 0.1 |
0.3 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.4 |
GO:0009071 |
glycine metabolic process(GO:0006544) glycine catabolic process(GO:0006546) serine family amino acid catabolic process(GO:0009071) |
| 0.1 |
0.3 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.1 |
1.9 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
0.1 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.1 |
0.1 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.1 |
0.3 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.1 |
0.1 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
3.5 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
| 0.1 |
0.3 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.1 |
1.4 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
1.8 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 |
2.6 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.1 |
GO:0090345 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 |
0.7 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 |
0.5 |
GO:0018101 |
protein citrullination(GO:0018101) |
| 0.1 |
0.5 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.3 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.3 |
GO:0030917 |
midbrain-hindbrain boundary development(GO:0030917) |
| 0.1 |
0.4 |
GO:1902692 |
regulation of neuroblast proliferation(GO:1902692) |
| 0.1 |
0.3 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.1 |
2.2 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.1 |
0.4 |
GO:0015807 |
L-amino acid transport(GO:0015807) |
| 0.1 |
0.5 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.1 |
1.7 |
GO:0007045 |
cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
| 0.1 |
0.6 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.1 |
GO:0016458 |
gene silencing(GO:0016458) |
| 0.1 |
0.6 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
0.9 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.1 |
0.1 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.1 |
GO:0051877 |
pigment granule aggregation in cell center(GO:0051877) |
| 0.1 |
0.4 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.1 |
0.1 |
GO:0006739 |
NADP metabolic process(GO:0006739) |
| 0.1 |
0.9 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.1 |
0.4 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.1 |
1.6 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
0.6 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.1 |
0.4 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 |
0.2 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.1 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.1 |
0.2 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.4 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
2.0 |
GO:0032963 |
collagen metabolic process(GO:0032963) |
| 0.1 |
0.1 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.1 |
0.3 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) positive regulation of pinocytosis(GO:0048549) positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.8 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
| 0.1 |
0.1 |
GO:0040020 |
regulation of meiotic nuclear division(GO:0040020) |
| 0.1 |
0.2 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 |
0.7 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.7 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
0.4 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.5 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.3 |
GO:0034331 |
cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
| 0.1 |
0.2 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.1 |
0.2 |
GO:0032228 |
regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.1 |
0.2 |
GO:0035269 |
protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
| 0.1 |
1.9 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.1 |
14.3 |
GO:0006936 |
muscle contraction(GO:0006936) |
| 0.1 |
0.2 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.1 |
0.5 |
GO:0030201 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.1 |
0.4 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.1 |
0.6 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.1 |
0.3 |
GO:0072523 |
purine-containing compound catabolic process(GO:0072523) |
| 0.1 |
0.4 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.1 |
GO:0055007 |
cardiac muscle cell differentiation(GO:0055007) |
| 0.1 |
0.8 |
GO:0006693 |
prostaglandin metabolic process(GO:0006693) |
| 0.1 |
0.2 |
GO:0001910 |
regulation of leukocyte mediated cytotoxicity(GO:0001910) |
| 0.1 |
0.2 |
GO:0015931 |
nucleobase-containing compound transport(GO:0015931) |
| 0.1 |
1.6 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.1 |
11.3 |
GO:0007517 |
muscle organ development(GO:0007517) |
| 0.1 |
0.3 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.1 |
GO:0014889 |
muscle atrophy(GO:0014889) peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
0.3 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.1 |
0.6 |
GO:0001666 |
response to hypoxia(GO:0001666) |
| 0.1 |
0.1 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.1 |
0.4 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.1 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 |
0.9 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
1.0 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.1 |
1.1 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.2 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.1 |
0.3 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.5 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
1.2 |
GO:0006490 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.1 |
GO:0060346 |
bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 0.1 |
0.1 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 |
0.3 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.1 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) lung secretory cell differentiation(GO:0061140) |
| 0.1 |
0.1 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.1 |
2.7 |
GO:0033572 |
ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.1 |
0.6 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.1 |
0.1 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.1 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
0.1 |
GO:0006448 |
regulation of translational elongation(GO:0006448) |
| 0.1 |
0.1 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.1 |
0.1 |
GO:0070244 |
negative regulation of T cell apoptotic process(GO:0070233) negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.1 |
0.2 |
GO:0032506 |
barrier septum assembly(GO:0000917) cytokinetic process(GO:0032506) cell septum assembly(GO:0090529) mitotic cytokinetic process(GO:1902410) |
| 0.1 |
0.7 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.1 |
0.3 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.4 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.1 |
0.3 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 |
0.1 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.1 |
1.6 |
GO:0043547 |
positive regulation of GTPase activity(GO:0043547) |
| 0.1 |
0.2 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) |
| 0.1 |
0.2 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
3.3 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.3 |
GO:0015886 |
heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 0.1 |
0.3 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.1 |
1.1 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.1 |
0.4 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.1 |
0.4 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.6 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.3 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.1 |
0.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.2 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.1 |
0.1 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.1 |
0.1 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
2.4 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
0.8 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.6 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
0.2 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
2.6 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.1 |
GO:0051168 |
nuclear export(GO:0051168) |
| 0.1 |
0.3 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.4 |
GO:0044070 |
regulation of anion transport(GO:0044070) |
| 0.1 |
0.1 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 |
0.1 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.1 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.1 |
GO:1901798 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 |
0.5 |
GO:0006681 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.1 |
0.6 |
GO:0051927 |
obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
| 0.1 |
0.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.9 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.1 |
0.2 |
GO:0006787 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 |
0.2 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.5 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
| 0.1 |
0.1 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
1.7 |
GO:0030837 |
negative regulation of actin filament polymerization(GO:0030837) |
| 0.1 |
0.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.2 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
2.9 |
GO:0071559 |
response to transforming growth factor beta(GO:0071559) cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.1 |
0.4 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.1 |
0.2 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
1.8 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.1 |
0.2 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 |
0.3 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.1 |
1.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.1 |
GO:0010834 |
obsolete telomere maintenance via telomere shortening(GO:0010834) |
| 0.1 |
1.0 |
GO:0007034 |
vacuolar transport(GO:0007034) |
| 0.1 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.1 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.1 |
0.1 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.1 |
0.1 |
GO:0030219 |
megakaryocyte differentiation(GO:0030219) |
| 0.1 |
0.2 |
GO:0006530 |
asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
| 0.1 |
1.1 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.7 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.1 |
0.3 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 |
0.5 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.9 |
GO:0051318 |
G1 phase(GO:0051318) |
| 0.1 |
0.3 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
| 0.1 |
0.1 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.1 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.1 |
0.1 |
GO:0000114 |
obsolete regulation of transcription involved in G1 phase of mitotic cell cycle(GO:0000114) |
| 0.1 |
0.1 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.1 |
0.2 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
2.0 |
GO:0051261 |
protein depolymerization(GO:0051261) |
| 0.1 |
0.4 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
| 0.1 |
0.2 |
GO:0019054 |
modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
| 0.1 |
0.1 |
GO:0050808 |
synapse organization(GO:0050808) |
| 0.1 |
1.7 |
GO:0007043 |
cell-cell junction assembly(GO:0007043) |
| 0.1 |
0.1 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 |
0.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.7 |
GO:0009855 |
determination of bilateral symmetry(GO:0009855) |
| 0.1 |
0.1 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.1 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
3.9 |
GO:0006200 |
obsolete ATP catabolic process(GO:0006200) |
| 0.1 |
0.4 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.1 |
GO:0071025 |
RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 |
0.4 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.1 |
0.3 |
GO:0032364 |
oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
| 0.1 |
1.3 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.1 |
0.2 |
GO:0048738 |
cardiac muscle tissue development(GO:0048738) |
| 0.1 |
0.1 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
0.2 |
GO:0034723 |
DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
1.7 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.1 |
0.7 |
GO:0009584 |
detection of visible light(GO:0009584) |
| 0.1 |
0.2 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.4 |
GO:0051591 |
response to cAMP(GO:0051591) |
| 0.1 |
0.1 |
GO:0009130 |
pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
| 0.1 |
0.1 |
GO:0090281 |
negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
| 0.1 |
0.1 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.1 |
0.2 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 |
0.4 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.1 |
0.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
1.3 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.2 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
0.2 |
GO:2000189 |
regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 |
0.1 |
GO:0048588 |
developmental cell growth(GO:0048588) |
| 0.0 |
0.7 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
2.3 |
GO:0016567 |
protein ubiquitination(GO:0016567) |
| 0.0 |
0.9 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.0 |
0.4 |
GO:0042987 |
amyloid precursor protein catabolic process(GO:0042987) |
| 0.0 |
0.0 |
GO:0072207 |
metanephric tubule development(GO:0072170) metanephric epithelium development(GO:0072207) metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
| 0.0 |
0.1 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.0 |
0.1 |
GO:0003077 |
obsolete negative regulation of diuresis(GO:0003077) |
| 0.0 |
0.3 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.1 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 |
0.4 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 |
1.8 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
0.5 |
GO:0050773 |
regulation of dendrite development(GO:0050773) |
| 0.0 |
0.1 |
GO:0042116 |
macrophage activation(GO:0042116) |
| 0.0 |
0.6 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.9 |
GO:0045768 |
obsolete positive regulation of anti-apoptosis(GO:0045768) |
| 0.0 |
0.2 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.0 |
0.1 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.5 |
GO:1901072 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 |
0.4 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.4 |
GO:0043545 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.2 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
2.3 |
GO:0006665 |
sphingolipid metabolic process(GO:0006665) |
| 0.0 |
0.4 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.1 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.4 |
GO:0042354 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.2 |
GO:0021987 |
cerebral cortex development(GO:0021987) |
| 0.0 |
0.3 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.0 |
0.6 |
GO:0032400 |
melanosome localization(GO:0032400) |
| 0.0 |
1.8 |
GO:0007588 |
excretion(GO:0007588) |
| 0.0 |
0.1 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 |
0.4 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.6 |
GO:0050931 |
melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
| 0.0 |
0.8 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.0 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.0 |
0.9 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.3 |
GO:0043068 |
positive regulation of cell death(GO:0010942) positive regulation of programmed cell death(GO:0043068) |
| 0.0 |
0.1 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.0 |
0.3 |
GO:0007626 |
locomotory behavior(GO:0007626) |
| 0.0 |
0.2 |
GO:0015827 |
tryptophan transport(GO:0015827) leucine import(GO:0060356) |
| 0.0 |
0.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
0.0 |
GO:0030500 |
regulation of bone mineralization(GO:0030500) |
| 0.0 |
0.1 |
GO:0070884 |
calcineurin-NFAT signaling cascade(GO:0033173) regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.2 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.0 |
GO:0008356 |
asymmetric cell division(GO:0008356) |
| 0.0 |
0.4 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.0 |
0.2 |
GO:0060014 |
granulosa cell differentiation(GO:0060014) |
| 0.0 |
0.0 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.1 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.0 |
0.1 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.3 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
1.6 |
GO:0006986 |
response to unfolded protein(GO:0006986) |
| 0.0 |
0.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.3 |
GO:0008334 |
histone mRNA metabolic process(GO:0008334) |
| 0.0 |
0.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) cytochrome complex assembly(GO:0017004) |
| 0.0 |
0.4 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.1 |
GO:0032042 |
mitochondrial DNA metabolic process(GO:0032042) |
| 0.0 |
2.0 |
GO:0043623 |
cellular protein complex assembly(GO:0043623) |
| 0.0 |
0.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.6 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.1 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.0 |
0.4 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 |
0.1 |
GO:0009103 |
lipopolysaccharide biosynthetic process(GO:0009103) |
| 0.0 |
0.1 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.0 |
0.0 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.0 |
0.1 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.0 |
0.0 |
GO:0043558 |
regulation of translational initiation in response to stress(GO:0043558) |
| 0.0 |
0.1 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
1.0 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.5 |
GO:0075713 |
establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
| 0.0 |
0.1 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.3 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.0 |
0.1 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
0.2 |
GO:1903019 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) negative regulation of glycoprotein metabolic process(GO:1903019) |
| 0.0 |
0.0 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.2 |
GO:0045446 |
endothelium development(GO:0003158) endothelial cell differentiation(GO:0045446) |
| 0.0 |
0.3 |
GO:0036336 |
dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
| 0.0 |
0.0 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.2 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.3 |
GO:0006561 |
proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
| 0.0 |
0.1 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 0.0 |
0.0 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.0 |
0.1 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 |
0.1 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.3 |
GO:0030030 |
cell projection organization(GO:0030030) |
| 0.0 |
0.1 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.0 |
0.1 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
0.0 |
GO:0072205 |
collecting duct development(GO:0072044) metanephric collecting duct development(GO:0072205) |
| 0.0 |
0.5 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.5 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.2 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.0 |
0.2 |
GO:1903301 |
regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.1 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.0 |
GO:0001824 |
blastocyst development(GO:0001824) |
| 0.0 |
0.0 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.0 |
0.1 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.2 |
GO:0051937 |
catecholamine transport(GO:0051937) |
| 0.0 |
0.2 |
GO:0030282 |
bone mineralization(GO:0030282) |
| 0.0 |
0.0 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.0 |
0.1 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.2 |
GO:0071514 |
genetic imprinting(GO:0071514) |
| 0.0 |
0.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
1.2 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.0 |
0.1 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.0 |
0.8 |
GO:0001764 |
neuron migration(GO:0001764) |
| 0.0 |
0.6 |
GO:0045216 |
cell-cell junction organization(GO:0045216) |
| 0.0 |
0.1 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.0 |
0.1 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.0 |
0.0 |
GO:2000050 |
regulation of non-canonical Wnt signaling pathway(GO:2000050) |
| 0.0 |
0.6 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.3 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.1 |
GO:0030104 |
water homeostasis(GO:0030104) |
| 0.0 |
0.0 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.0 |
0.0 |
GO:0072677 |
eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
| 0.0 |
0.2 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) |
| 0.0 |
0.2 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.1 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.0 |
0.1 |
GO:0042749 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 |
0.1 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.2 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.7 |
GO:0044349 |
nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
| 0.0 |
0.1 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.1 |
GO:0042816 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
| 0.0 |
0.1 |
GO:0044321 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) negative regulation of gluconeogenesis(GO:0045721) detection of glucose(GO:0051594) |
| 0.0 |
0.1 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.0 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.2 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.0 |
0.0 |
GO:0031497 |
chromatin assembly(GO:0031497) |
| 0.0 |
0.4 |
GO:0035967 |
cellular response to topologically incorrect protein(GO:0035967) |
| 0.0 |
0.0 |
GO:0000239 |
pachytene(GO:0000239) |
| 0.0 |
0.5 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.0 |
GO:0006386 |
transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
| 0.0 |
0.1 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
| 0.0 |
0.1 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.0 |
0.1 |
GO:0072164 |
ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
| 0.0 |
0.0 |
GO:0060291 |
long-term synaptic potentiation(GO:0060291) |
| 0.0 |
0.2 |
GO:0009187 |
cyclic nucleotide metabolic process(GO:0009187) |
| 0.0 |
0.0 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.0 |
0.1 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 |
1.4 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.2 |
GO:0048246 |
macrophage chemotaxis(GO:0048246) |
| 0.0 |
0.0 |
GO:0050918 |
positive chemotaxis(GO:0050918) |
| 0.0 |
0.1 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.1 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.1 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.0 |
2.9 |
GO:0030036 |
actin cytoskeleton organization(GO:0030036) |
| 0.0 |
0.0 |
GO:0046618 |
drug export(GO:0046618) |
| 0.0 |
0.1 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.0 |
0.9 |
GO:0007565 |
female pregnancy(GO:0007565) |
| 0.0 |
0.0 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
| 0.0 |
0.0 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.0 |
0.1 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.6 |
GO:0031123 |
RNA 3'-end processing(GO:0031123) |
| 0.0 |
0.5 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
0.0 |
GO:0010332 |
response to gamma radiation(GO:0010332) |
| 0.0 |
0.6 |
GO:0071772 |
BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
| 0.0 |
0.2 |
GO:0007567 |
parturition(GO:0007567) |
| 0.0 |
2.4 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.1 |
GO:0070542 |
response to fatty acid(GO:0070542) |
| 0.0 |
0.0 |
GO:0034371 |
chylomicron remodeling(GO:0034371) |
| 0.0 |
0.1 |
GO:0021846 |
cell proliferation in forebrain(GO:0021846) |
| 0.0 |
0.4 |
GO:0006081 |
cellular aldehyde metabolic process(GO:0006081) |
| 0.0 |
0.0 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.0 |
0.2 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.0 |
0.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.1 |
GO:0055072 |
iron ion homeostasis(GO:0055072) |
| 0.0 |
0.1 |
GO:0071599 |
otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
| 0.0 |
0.1 |
GO:0071320 |
cellular response to cAMP(GO:0071320) |
| 0.0 |
0.1 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.0 |
2.3 |
GO:0006403 |
RNA localization(GO:0006403) |
| 0.0 |
0.7 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.0 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.0 |
0.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 |
0.1 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.0 |
0.0 |
GO:0009583 |
detection of light stimulus(GO:0009583) |
| 0.0 |
0.1 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.0 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 |
0.6 |
GO:0002576 |
platelet degranulation(GO:0002576) |
| 0.0 |
2.1 |
GO:0001558 |
regulation of cell growth(GO:0001558) |
| 0.0 |
0.1 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 |
0.2 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 |
0.1 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.1 |
GO:0014014 |
negative regulation of gliogenesis(GO:0014014) |
| 0.0 |
1.3 |
GO:0006457 |
protein folding(GO:0006457) |
| 0.0 |
0.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.0 |
0.0 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.0 |
0.3 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.0 |
GO:0050710 |
negative regulation of cytokine secretion(GO:0050710) |
| 0.0 |
0.2 |
GO:0001502 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.0 |
4.5 |
GO:0097485 |
axon guidance(GO:0007411) neuron projection guidance(GO:0097485) |
| 0.0 |
0.1 |
GO:0030277 |
epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.0 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.0 |
0.1 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.0 |
GO:1902170 |
cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
| 0.0 |
0.1 |
GO:0002068 |
glandular epithelial cell development(GO:0002068) |
| 0.0 |
0.0 |
GO:0008653 |
lipopolysaccharide metabolic process(GO:0008653) |
| 0.0 |
0.1 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 |
0.2 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.0 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) cellular component maintenance(GO:0043954) |
| 0.0 |
0.1 |
GO:0051053 |
negative regulation of DNA metabolic process(GO:0051053) |
| 0.0 |
0.0 |
GO:0042523 |
regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.0 |
0.0 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.2 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.0 |
0.1 |
GO:0006555 |
methionine metabolic process(GO:0006555) |
| 0.0 |
0.1 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.0 |
0.3 |
GO:0006818 |
hydrogen transport(GO:0006818) |
| 0.0 |
0.0 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.1 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
| 0.0 |
0.1 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.0 |
0.1 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.1 |
GO:0009450 |
gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.0 |
0.1 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.0 |
0.0 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.0 |
0.0 |
GO:0048710 |
regulation of astrocyte differentiation(GO:0048710) |
| 0.0 |
0.1 |
GO:0030278 |
regulation of ossification(GO:0030278) |
| 0.0 |
0.0 |
GO:0051657 |
maintenance of organelle location(GO:0051657) |
| 0.0 |
0.5 |
GO:0006754 |
ATP biosynthetic process(GO:0006754) |
| 0.0 |
0.1 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.0 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 |
0.0 |
GO:0007285 |
primary spermatocyte growth(GO:0007285) |
| 0.0 |
0.1 |
GO:0032106 |
positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.0 |
0.2 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.0 |
0.7 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
1.0 |
GO:0034728 |
nucleosome organization(GO:0034728) |
| 0.0 |
0.0 |
GO:0015838 |
quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
| 0.0 |
0.1 |
GO:0031427 |
response to methotrexate(GO:0031427) |
| 0.0 |
0.1 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.0 |
GO:0009648 |
photoperiodism(GO:0009648) |
| 0.0 |
0.1 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:0032677 |
regulation of interleukin-8 production(GO:0032677) |
| 0.0 |
0.0 |
GO:0002027 |
regulation of heart rate(GO:0002027) |
| 0.0 |
0.2 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
0.0 |
GO:1901992 |
positive regulation of cell cycle phase transition(GO:1901989) positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.0 |
0.1 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.0 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.0 |
0.0 |
GO:0016265 |
obsolete death(GO:0016265) |
| 0.0 |
0.0 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.3 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
| 0.0 |
0.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
